Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Isomorphic Labs: The company raised GBP 449 million of venture funding in a deal led by Thrive Capital on March 31, 2025, putting the company’s pre-money valuation at GBP 942...
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Supira Medical: The company raised $120 million of Series E venture funding in a deal led by Novo Holdings and Qatar Investment Authority on March 26, 2025, putting the...
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Latigo Bio: The company raised $150 million of Series B venture funding in a deal led by Blue Owl Capital on March 17, 2025, putting the company’s pre-money valuation at $380...
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions BVI Medical: The company received $1 billion of development capital from TPG and other undisclosed investors on March 10, 2025. The company is a manufacturer of surgical devices...
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Callio Therapeutics: The company raised $187 million of Series A venture funding in a deal led by Frazier Healthcare Partners on March 3, 2025. Novo Holdings, Norwest Holdings, SEEDS...
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Eikon Therapeutics: The company raised $350.7 million of Series D venture funding from Foresite Capital, Lux Capital and The Column Group on February 26, 2025, putting the...
